Allianz SE : Towards the breakout of a major resistance level
| Entry price | Target | Stop-loss | Potential |
|---|
|
€376.7 |
€400 |
€359 |
+6.19% |
|---|
Shares in Allianz SE are approaching an important resistance level. The stock's technical chart suggests that this pivot level will be broken.
Summary● The company has a good ESG score relative to its sector, according to MSCI.
● The earnings growth currently anticipated by analysts for the coming years is particularly strong.
● The company returns high margins, thereby supporting business profitability.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 13.05 for the current year.
● This company will be of major interest to investors in search of a high dividend stock.
● The opinion of analysts covering the stock has improved over the past four months.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● Most analysts recommend that the stock should be sold or reduced.
● Over the past twelve months, analysts' opinions have been revised negatively.
© MarketScreener.com -
2025
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener India. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
